Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-09

Clinical Trial Update: Microwave Ablation of Primary and Secondary Lung Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating microwave ablation for primary and secondary lung cancers; status current as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microwave ablation (microwave ablation)

Snippet

Sponsor: University of Calgary | Conditions: Lung Neoplasms, Neoplasm Metastasis | Phase 1, Phase 2 | Status: UNKNOWN